EyePoint, Inc. (EYPT)
0.4045
-0.02
(-5.51%)
USD |
NASDAQ |
Oct 23, 16:00
0.413
+0.01
(+2.10%)
Pre-Market: 20:00
EyePoint Price to Book Value : 0.2066 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.2066 |
| October 22, 2026 | 0.2186 |
| October 21, 2026 | 0.2196 |
| October 20, 2026 | 0.2069 |
| October 19, 2026 | 0.2247 |
| October 16, 2026 | 1.527 |
| October 15, 2026 | 1.604 |
| October 14, 2026 | 1.537 |
| October 13, 2026 | 1.568 |
| October 12, 2026 | 1.695 |
| October 09, 2026 | 1.736 |
| October 08, 2026 | 1.767 |
| October 07, 2026 | 1.695 |
| October 06, 2026 | 1.619 |
| October 05, 2026 | 1.609 |
| October 02, 2026 | 1.660 |
| October 01, 2026 | 1.650 |
| September 30, 2026 | 1.670 |
| September 29, 2026 | 1.746 |
| September 28, 2026 | 1.690 |
| September 25, 2026 | 1.849 |
| September 24, 2026 | 1.864 |
| September 23, 2026 | 1.900 |
| September 22, 2026 | 2.078 |
| September 21, 2026 | 2.053 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.966 |
| September 17, 2026 | 2.038 |
| September 16, 2026 | 1.762 |
| September 15, 2026 | 1.869 |
| September 14, 2026 | 2.170 |
| September 11, 2026 | 2.160 |
| September 10, 2026 | 2.170 |
| September 09, 2026 | 2.216 |
| September 08, 2026 | 2.329 |
| September 04, 2026 | 2.339 |
| September 03, 2026 | 2.331 |
| September 02, 2026 | 2.446 |
| September 01, 2026 | 2.339 |
| August 31, 2026 | 2.298 |
| August 28, 2026 | 2.288 |
| August 27, 2026 | 2.364 |
| August 26, 2026 | 2.548 |
| August 25, 2026 | 2.556 |
| August 24, 2026 | 2.487 |
| August 21, 2026 | 2.717 |
| August 20, 2026 | 2.758 |
| August 19, 2026 | 3.217 |
| August 18, 2026 | 2.793 |
| August 17, 2026 | 2.487 |
| August 14, 2026 | 7.532 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ocular Therapeutix, Inc. | 2.745 |
| Regeneron Pharmaceuticals, Inc. | 2.625 |
| Corcept Therapeutics, Inc. | 13.13 |
| Eli Lilly & Co. | 35.39 |
| Nuvation Bio, Inc. | 6.298 |
Price to Book Value Related Metrics
| PS Ratio | 11.81 |
| PEG Ratio | -0.0027 |
| Price | 0.4045 |
| Earnings Yield | -925.5% |
| Market Cap | 34.38M |
| PEGY Ratio | -0.0027 |